"The snowboarding minigame is just essential to FF7 as a whole," says Hamaguchi. He's totally correct. Cloud dealing with ...

Final Fantasy 7 Revelation will let players access Hard Mode from the very beginning of the journey, unlike FF7 Remake and Rebirth, which made folks roll credits before unlocking the tougher ...

SAUSALITO, Calif., Oct. 25, 2023 /PRNewswire/ -- Revelation Partners today announced the closing of its $608 million Fund IV, far surpassing the healthcare investment firm's initial target of $500 ...

During an interview with MisterMV, Hamaguchi spoke about Final Fantasy VII Revelation’s playable demo at Paris Games Week.

Now over 100 hours in, catch up on the events of the first two parts of the Final Fantasy 7 Remake trilogy ...

FF7 Revelation is redefining 'open world' Final Fantasy 7 Revelation, the third and final (sorry) installment of Square Enix’s FF7 remake trilogy, puts a cap on this seven-year-long series. It picks ...

Final Fantasy 7 Revelation game director Naoki Hamaguchi took the stage to reveal more about the trilogy's climactic conclusion. The new trailer focused heavily on the game's Weapons, extremely ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Final Fantasy Revelation is the third game in the remake trilogy ...

FF7 Revelation took 3 years vs the usual 5+ because 95% of the team stayed from Rebirth. Square Enix’s most efficient cycle ever. Final Fantasy VII Revelation, the conclusion to the remake trilogy, ...

What is revelation? My definition broadens almost by the day. Sometimes I hear measures of a song so searingly truthful or beautiful they seem like prayer. Or I see a swallow swooping across a ...

HOPE THEY SURVIVE THE EXPERIENCE! X YEARS LATER, on the run after a deadly clash with Revelation’s chief assassin, the shattered X-Men desperately gamble everything on one last mission. With help from ...

NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (“Revelation”), a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention ...